Grant: CIHR Fellowship
University of Calgary
$45,000.00
Drip and Ship vs. Mothership in the Era of Neuroprotection and the RACE-CAT Trial: Validation and Iteration of a Predictive Model for Most Optimal Transport and Treatment Strategy for Acute Ischemic Stroke Patients with Suspected Large Vessel Occlusion
FY 2020-21
Summary
An ischemic stroke occurs when a blood clot blocks blood flow to an area of the brain, similar to a clog in a pipe. When this happens, the brain becomes deprived of oxygen and irreversible damage begins to occur. Patients need to be treated quickly after signs of a stroke begin to improve their chance of survival and prevent disability. There are two treatment options for stroke patients: medication to dissolve the blood clot, or surgery to remove the clot. These treatment options can be combined. The clot-dissolving drug can be administered at many hospitals across the country but is only effective 30% of the time. The surgical procedure is > 80% effective, but it requires specialized equipment and specially trained physicians so it can only be performed at a few large urban hospitals. This means there are two options for patients who are far away from large hospitals: 1) go to the closest hospital for quick but less effective treatment (clot-dissolving drug) and then be transferred to a large hospital for more effective treatment later (surgical procedure); or 2) spend extra time upfront being transported to the larger hospital for more effective treatment (surgical procedure). Previously, I developed an algorithm that predicts which option is best based on distances travelled and the length of time it takes to administer treatments.
Stroke care has improved in the past few years and now it is time to improve the algorithm. The algorithm needs to be validated. This will be done using data from a recent clinical trial that tested the two transport options listed above. Second, there are new medical treatments available for ischemic stroke now (neuroprotective agents which temporarily "freeze" cell death) and we need to put this option in the algorithm too. This updated algorithm will ensure that all stroke patients, regardless of where they live, receive the best possible care.
Department
Program
CIHR Fellowship
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
440368
Name
Holodinsky Jessalyn K
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Drip and Ship vs. Mothership in the Era of Neuroprotection and the RACE-CAT Trial: Validation and Iteration of a Predictive Model for Most Optimal Transport and Treatment Strategy for Acute Ischemic Stroke Patients with Suspected Large Vessel Occlusion
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Ischemic Stroke; Predictive Modelling; Validation Study
Abstract
An ischemic stroke occurs when a blood clot blocks blood flow to an area of the brain, similar to a clog in a pipe. When this happens, the brain becomes deprived of oxygen and irreversible damage begins to occur. Patients need to be treated quickly after signs of a stroke begin to improve their chance of survival and prevent disability. There are two treatment options for stroke patients: medication to dissolve the blood clot, or surgery to remove the clot. These treatment options can be combined. The clot-dissolving drug can be administered at many hospitals across the country but is only effective 30% of the time. The surgical procedure is > 80% effective, but it requires specialized equipment and specially trained physicians so it can only be performed at a few large urban hospitals. This means there are two options for patients who are far away from large hospitals: 1) go to the closest hospital for quick but less effective treatment (clot-dissolving drug) and then be transferred to a large hospital for more effective treatment later (surgical procedure); or 2) spend extra time upfront being transported to the larger hospital for more effective treatment (surgical procedure). Previously, I developed an algorithm that predicts which option is best based on distances travelled and the length of time it takes to administer treatments.
Stroke care has improved in the past few years and now it is time to improve the algorithm. The algorithm needs to be validated. This will be done using data from a recent clinical trial that tested the two transport options listed above. Second, there are new medical treatments available for ischemic stroke now (neuroprotective agents which temporarily "freeze" cell death) and we need to put this option in the algorithm too. This updated algorithm will ensure that all stroke patients, regardless of where they live, receive the best possible care.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Holodinsky, Jessalyn K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $45,000~ $0~